Earnings History Data for Dyadic International, Inc. (DYAI) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Dyadic International, Inc.

Dyadic International, Inc. is a leading genomics company with the groundbreaking technology that brings nature to the marketplace. Dyadic is poised to become a global leader in proteomics through the discovery, development, and manufacturing of novel products derived from the DNA of complex living organisms including humans found in the earth's biodiversity. Using its integrated technology platform, Dyadic develops biological products such as proteins, enzymes, polypeptides and small molecules for applications in large segments of the agricultural, industrial, chemical and biopharmaceutical industries. By utilizing a proprietary host organism, Dyadic's `one-stop shop` technology rapidly discovers and expresses eukaryotic genes the genes of complex living organisms and then manufactures those unique biological products for commercial application. Dyadic's systems overcome the inadequacy of existing gene discovery and product development techniques.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-11-2024	AH		DYAI	Dyadic International, Inc.	33.60	-0.01	-0.07	-0.06	Dyadic International GAAP EPS of -$0.01 beats by $0.06, revenue of $1.95M beats by $0.85M [11/12/2024 4:54 PM]	1.12	-0.02 (-1.75%)	1.15	0.01 (0.88%)	0.93 - 2.67	22,592	20,000	505
Dyadic International GAAP EPS of -$0.01 beats by $0.06, revenue of $1.95M beats by $0.85M [11/12/2024 4:54 PM] Earnings To Watch: Dyadic International Inc (DYAI) Reports Q3 2024 Result [Nov-11-24 07:27AM]
13-08-2024	AH		DYAI	Dyadic International	41.00	-0.07	-0.07	0.00	Dyadic International GAAP EPS of -$0.07 in-line, revenue of $385.89M beats by $384.89M [8/13/2024 4:12 PM]	1.37	0.02 (1.47%)	1.25	-0.10 (-7.41%)	1.19 - 2.67	32,956	30,000	4,132
Dyadic International GAAP EPS of -$0.07 in-line, revenue of $385.89M beats by $384.89M [8/13/2024 4:12 PM]
14-05-2024	AH		DYAI	Dyadic International, Inc.	42.01	-0.07	0.00	-0.03	Dyadic International GAAP EPS of -$0.07, revenue of $0.34M [5/14/2024 4:11 PM]	1.57	0.08 (5.37%)	1.50	0.01 (0.67%)	1.19 - 2.40	103,587	20,000	6,632
Dyadic International GAAP EPS of -$0.07, revenue of $0.34M [5/14/2024 4:11 PM]
28-03-2024	AH		DYAI	Dyadic International, Inc.	45.52	-0.08	-0.06	-0.07	Dyadic International GAAP EPS of -$0.24 misses by $0.01, revenue of $2.9M misses by $0.15M [3/28/2024 4:03 PM]	1.67	0.04 (2.45%)	1.75	0.08 (4.79%)	1.19 - 2.40	27,947	20,000	1,982
Dyadic International GAAP EPS of -$0.24 misses by $0.01, revenue of $2.9M misses by $0.15M [3/28/2024 4:03 PM] Dyadic's Michael Tarnok to step down as Chairman of the board of directors [3/28/2024 8:58 AM]
08-11-2023	AH		DYAI	Dyadic International, Inc.	48.11	-0.06	-0.06	-0.06	Dyadic International GAAP EPS of -$0.06, revenue of $0.4M [11/8/2023 5:31 PM]	1.58	-0.10 (-5.95%)	0.0	0.0 (0.00%)	1.12 - 2.40	7,563	20,000	0
Dyadic International GAAP EPS of -$0.06, revenue of $0.4M [11/8/2023 5:31 PM]
09-08-2023	AH		DYAI	Dyadic International, Inc.	49.27	-0.07	-0.05	-0.12	Dyadic International GAAP EPS of -$0.07 misses by $0.02, revenue of $837.15M [8/9/2023 4:38 PM]	1.95	0.15 (8.33%)	0.0	0.0 (0.00%)	1.12 - 3.02	80,804	10,000	0
Dyadic International GAAP EPS of -$0.07 misses by $0.02, revenue of $837.15M [8/9/2023 4:38 PM]
10-05-2023	AH	4:00 PM ET (May 10)	DYAI	Dyadic International, Inc.	50.36	-0.03	0.00	-0.09	Dyadic International GAAP EPS of -$0.03, revenue of $0.98M [5/10/2023 4:21 PM]	1.90	0.18 (10.47%)	0.0	0.0 (0.00%)	1.12 - 3.56	32,154	30,000	0
Dyadic International GAAP EPS of -$0.03, revenue of $0.98M [5/10/2023 4:21 PM]
29-03-2023	AH	4:00 PM ET (Mar 29)	DYAI	Dyadic International	40.00	-0.07	-0.07	0.00	Dyadic International GAAP EPS of -$0.34 in-line, revenue of $2.93M misses by $0.72M [3/29/2023 4:06 PM]	1.78	0.29 (19.46%)	0.0	0.0 (0.00%)	1.12 - 3.56	152,893	20,000	0
Dyadic International GAAP EPS of -$0.34 in-line, revenue of $2.93M misses by $0.72M [3/29/2023 4:06 PM]
10-11-2022	AH	4:00 PM ET (Nov 10)	DYAI	Dyadic International, Inc.	60.26	-0.06	-0.09	-0.06	Dyadic International GAAP EPS of -$0.06 beats by $0.04, revenue of $0.88M misses by $1.02M [11/10/2022 4:01 PM]	1.91	-0.16 (-7.97%)	0.0	0.0 (0.00%)	1.58 - 4.98	83,265	20,000	0
Dyadic International GAAP EPS of -$0.06 beats by $0.04, revenue of $0.88M misses by $1.02M [11/10/2022 4:01 PM] Dyadic Reports Third Quarter 2022 Financial Results and Highlights Recent Company Developments [Nov-10-22 04:00PM]
10-08-2022	AH	4:00 PM ET (Aug 10)	DYAI	Dyadic International, Inc.	84.51	-0.12	-0.09	-0.14	Dyadic International GAAP EPS of -$0.12 misses by $0.05, revenue of $6.58M beats by $4.18M [8/10/2022 4:03 PM]	2.57	-0.11 (-4.10%)	0.0	0.0 (0.00%)	1.74 - 6.89	60,461	50,000	0
Dyadic International GAAP EPS of -$0.12 misses by $0.05, revenue of $6.58M beats by $4.18M [8/10/2022 4:03 PM] Dyadic Reports Second Quarter 2022 Financial Results and Highlights Recent Company Developments [Aug-10-22 04:00PM]
12-05-2022	AH	4:00 PM ET (May 12)	DYAI	Dyadic International, Inc.	52.85	-0.09	-0.09	0.00	Dyadic International GAAP EPS of -$0.09 beats by $0.05, revenue of $0.65M misses by $0.85M [5/12/2022 4:03 PM]	2.24	0.16 (7.69%)	2.08	0.0 (0.00%)	1.74 - 6.89	54,241	50,000	405
Dyadic International GAAP EPS of -$0.09 beats by $0.05, revenue of $0.65M misses by $0.85M [5/12/2022 4:03 PM] Dyadic Announces Research, License and Collaboration for the Manufacture of Animal Free Ingredients [May-11-22 08:30AM] Dyadic Reports First Quarter 2022 Financial Results and Highlights Recent Company Developments [May-12-22 04:00PM] DYAI: First Quarter 2022 Operational & Financial Results [May-13-22 06:55AM]
29-03-2022	AH	4:00 PM ET (Mar 29)	DYAI	Dyadic International, Inc.	92.10	-0.15	-0.04	0.00	Dyadic International GAAP EPS of -$0.47 misses by $0.09, revenue of $2.4M misses by $5.6M [3/29/2022 4:04 PM]	3.24	-0.08 (-2.55%)	3.38	0.06 (1.81%)	3.15 - 6.89	77,732	40,000	696
Dyadic International GAAP EPS of -$0.47 misses by $0.09, revenue of $2.4M misses by $5.6M [3/29/2022 4:04 PM] Dyadic Reports 2021 Year End Results and Recent Company Progress [Mar-29-22 04:00PM] DYAI: 2021 Results [Mar-30-22 06:10AM]
10-11-2021	AH	7:10 PM ET (Nov 10)	DYAI	Dyadic International, Inc.	115.41	-0.06	-0.10	-0.09	Dyadic International EPS beats by $0.04, misses on revenue [11/10/2021 4:05 PM]	4.00	0.09 (2.35%)	0.0	0.0 (0.00%)	3.15 - 8.78	372,211	120,000	0
Dyadic International EPS beats by $0.04, misses on revenue [11/10/2021 4:05 PM] Dyadic Appoints Chief Business Officer to Executive Leadership Team [Nov-09-21 08:30AM] Dyadic Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress [Nov-10-21 04:00PM] DYAI: Two New Deals & A Pharma in the Wings [Nov-11-21 08:00AM]
12-08-2021	AH		DYAI	Dyadic International, Inc.	98.92	-0.14	-0.09	-0.10	Dyadic International EPS misses by $0.05, beats on revenue [8/12/2021 4:37 PM]	4.74	-0.13 (-2.67%)	4.45	-0.42 (-8.62%)	3.15 - 8.90	4,252,454	10,960,000	112,959
Dyadic International EPS misses by $0.05, beats on revenue [8/12/2021 4:37 PM] Sorrento and Dyadic Announce Binding Term Sheet to License Dyadics Lead COVID-19 Vaccine Candidate DYAI-100 and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics [Aug-11-21 09:00AM] Dyadic and Sorrento Announce Binding Term Sheet to License Dyadics Lead COVID-19 Vaccine Candidate DYAI-100 and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics [Aug-11-21 08:35AM] Dyadic Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress [Aug-12-21 04:00PM]
13-05-2021	AH		DYAI	Dyadic International, Inc.	113.25	N/A	0.09	-0.08	Dyadic International reports Q1 results [5/13/2021 4:25 PM]	3.71	-0.13 (-3.39%)	3.70	-0.14 (-3.65%)	3.51 - 10.98	141,001	190,000	7,973
Dyadic International reports Q1 results [5/13/2021 4:25 PM] Dyadic International, Inc. to Host Earnings Call [May-13-21 03:15PM] Dyadic Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress [May-13-21 04:00PM]
30-03-2021	AH	6:55 PM ET (Mar 30)	DYAI	Dyadic International, Inc.	141.26	N/A	-0.08	-0.07	Dyadic International EPS beats by $0.01, misses on revenue [3/30/2021 4:03 PM]	5.53	0.26 (4.93%)	5.27	0.0 (0.00%)	4.56 - 10.98	249,509	3,090,000	559
Dyadic International EPS beats by $0.01, misses on revenue [3/30/2021 4:03 PM] CEOs Presenting on the Emerging Growth Conference on March 31. Register now. [Mar-29-21 07:00AM] UPDATE -- Dyadic Advancing Proprietary Owned COVID-19 vaccine candidate, DYAI-100, Towards Human Clinical Trial [Mar-29-21 08:30AM] Dyadic International, Inc. to Host Earnings Call [Mar-30-21 02:45PM] Dyadic Reports 2020 Year End Results and Recent Company Progress [Mar-30-21 04:00PM]
12-11-2020	AH		DYAI	Dyadic International, Inc.	189.90	-0.09	-0.08	-0.06	Dyadic International reports Q3 results [11/12/2020 4:53 PM]	6.42	-0.27 (-4.04%)	6.50	-0.19 (-2.84%)	2.51 - 10.98	127,488	72,213	1,257

13-08-2020	AH	After the close (Aug 13)	DYAI	Dyadic International, Inc.	244.75	-0.10	-0.05	-0.10	Dyadic International EPS misses by $0.03, beats on revenue [8/13/2020 4:35 PM]	7.90	-0.99 (-11.09%)	8.67	-0.22 (-2.47%)	2.51 - 10.98	427,762	97,404	739

14-05-2020	AH		DYAI	Dyadic International, Inc.	178.11	-0.08	-0.02	-0.08		5.98	-0.29 (-4.63%)	6.59	0.32 (5.10%)	2.51 - 8.00	318,645	384,429	100